IDEC Pharmaceuticals
	Developer of products for the treatment of cancer and autoimmune diseases. The company was founded with the intent of developing and commercializing monoclonal antibodies. The company looks to find patient specific approaches in treating non-Hodgkin\'s lymphoma.
	['', 'cancer and autoimmune disease', ' ', 'treating lymphoma', ' ', 'patient specific', ' ', 'monoclonal antibody', '']
Sensorbit Systems
	Developer of vapor-sensing technology. The company is developing and commercializing a technology capable of detecting trace amounts of complex chemical vapors within seconds. The company plans to utilize this technology for sensor integration into cell phones and other portable devices, as well as the construction of small portable self-contained units in forms such as badges, buttons, and tags
	['chip ', 'chemical vapour', ' ', 'vapor sensing', ' ', 'sensor-on-chip', '']
Affimed Therapeutics
	Developer of unique TandAb antibody therapeutics for cancer and inflammatory diseases. The company offers anticancer drug candidates, including AFM13, a bispecific and tetravalent human antibody to treat Hodgkin Lymphoma, AFM11 and AFM15 for the treatment of Non-Hodgkin Lymphoma and autoimmune diseases.
	['', 'inflammatory diseases', ' antibody Lymphoma']
BioInvent
	Developer of antibody-based drug therapies for the treatment of cancer. The company has a pipeline of three proprietary antibodies focused on treatment for multiple myeloma, non-Hodgkin lymphoma and medulloblastoma.
	['', 'antibody drugs', ' ', 'drug developer', ' ', 'multiple myeloma', ' ', 'non-Hodgkin lymphoma', '']
